TITLE

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

AUTHOR(S)
Paré, L.; Marcuello, E.; Altés, A.; Del Río, E.; Sedano, L.; Salazar, J.; Cortés, A.; Barnadas, A.; Baiget, M.
PUB. DATE
April 2009
SOURCE
British Journal of Cancer;4/21/2009, Vol. 100 Issue 8, p1368
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction notice
ABSTRACT
A correction to the article "Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-flourouracil as first-line chemotherapy," by E. Marcuello and colleagues is presented.
ACCESSION #
37591413

 

Related Articles

  • Sizingup the SNP Sector.  // PharmaGenomics;Mar/Apr2003, Vol. 3 Issue 3, p10 

    Presents information on the new report 'Pharmacogenomics: A Strategic Market Outlook and Business Analysis,' which was released by Front Line Strategic Consulting Inc. in San Mateo, California as of March 2003. Projected growth in single nucleotide polymorphism genotyping and diagnostics;...

  • Pharmacogenetic perspectives on susceptibility to toxic industrial chemicals Vesell, E. S. // British Journal of Industrial Medicine;Aug1987, Vol. 44 Issue 8, p505 

    No abstract available.

  • The Implications of Population Admixture in Race-based Drug Prescription. Suarez-Kurtz, G. // Clinical Pharmacology & Therapeutics;Mar2008, Vol. 83 Issue 3, p399 

    A letter to the editor is presented in response to the article "The ethical implications of stratifying by race in pharmacogenomics," by Lee and "Enhancing race-based prescribing prescription with pharcogenomis by Nguyen and others.

  • Complexity and Pharmacogenomics. Licinio, J.; Wong, M-L // Pharmacogenomics Journal;2002, Vol. 2 Issue 4, p203 

    Editorial. Introduces a series of articles which explores the relevance of the science of complexity to pharmacogenomics.

  • In This Issue.  // Pharmacogenomics Journal;2005, Vol. 5 Issue 3, p143 

    Introduces a series of articles about pharmacogenomics.

  • MedCAC likes two gene tests.  // Medical Device Daily;2/4/2010, Vol. 14 Issue 23, p6 

    The article reports on the ratings given by the U.S. Medicare Coverage and Evidence Development Committee (MedCAC) on several pharmacogenomic testing, including the CYP2D6 gene for assessing the effectiveness of tamoxifen on breast cancer and the gene test for the colon cancer indicator UGT1A1.

  • In This Issue.  // Pharmacogenomics Journal;2005, Vol. 5 Issue 2, p71 

    Introduces a series of articles on pharmacogenomics.

  • State of the art and electronic submission of manuscripts. Licinio, Julio // Pharmacogenomics Journal;2002, Vol. 2 Issue 1, p1 

    Deals with the state of the art in the field of pharmacogenomics.

  • In This Issue.  // Pharmacogenomics Journal;2002, Vol. 2 Issue 1, p2 

    Introduces a series of articles related to pharmacogenomics.

  • Opportunities for advanced training. Thompson, Cheryl A. // American Journal of Health-System Pharmacy;9/15/2013, Vol. 70 Issue 18, p1560 

    The article focuses on the postgraduate year 2 (PGY2) residency program on pharmacogenetics or pharmacogenomics for pharmacists being offered at St. Jude Children's Research Hospital in Memphis, Tennessee.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics